Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03705273 · ClinicalTrials.gov registry record · Phase 4

Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup

A Phase 4 study, sponsored by Vanderbilt University Medical Center.

Terminated
Registry status
Phase 4
Development phase
40
Enrollment target

NCT03705273: Clinical Trial Phase 4 study, sponsored by Vanderbilt University Medical Center.

NCT03705273 is a Phase 4 study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03705273, a Phase 4 study, was terminated before completion, sponsored by Vanderbilt University Medical Center.

TERMINATED
Registry status
Phase 4
Development phase
40 participants
Enrollment target

Study Summary

Study of the palatability and acceptability of dexamethasone oral tablets crushed and placed in apple sauce or pudding in comparison with the IV solution mixed with sugar syrup and given orally. It is hypothesized that dexamethasone tablets crushed and administered in apple sauce or pudding will be more palatable and acceptable for pediatric patients receiving dexamethasone for an acute asthma exacerbation or croup.

Primary Outcome

Presence of nausea after medication administration (yes/no) measured by participant self-report

Interventions

  • DRUG Dexamethasone IV for PO
  • DRUG Dexamethasone crushed tablets

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-10-23
Est. Completion 2020-10-02
Phase Phase 4

Why NCT03705273 stopped before completion

NCT03705273 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Dexamethasone IV for PO is the first listed.

NCT03705273 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03705273 about?

NCT03705273 is a clinical study titled "Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup". Study of the palatability and acceptability of dexamethasone oral tablets crushed and placed in apple sauce or pudding in comparison with the IV solution mixed with sugar syrup and given orally. It is hypothesized that dexamethasone tablets crushed and administered in apple sauce or pudding will be ...

What is the current status of trial NCT03705273?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2018-10-23. Estimated completion is 2020-10-02.

What interventions are being tested in trial NCT03705273?

The interventions under investigation include: Dexamethasone IV for PO (DRUG), Dexamethasone crushed tablets (DRUG).

Who is sponsoring clinical trial NCT03705273?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03705273's enrollment target sits among peer trials

40 1397th of 2000 higher than 533 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03705273, the US trial registry maintained by the National Library of Medicine. NCT03705273 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.